ACell
Developing and commercializing advanced extracellular matrix devices for effective tissue and organ repair across various surgical procedures.
Developing and commercializing advanced extracellular matrix devices for effective tissue and organ repair across various surgical procedures.
ACell is a company dedicated to the development and commercialization of advanced extracellular matrix devices used for effective tissue and organ repair during various surgical procedures. Founded in 1999, the company is headquartered in Columbia, Maryland, and operates a manufacturing facility in Lafayette, Indiana. ACell's product line includes MatriStem technology, MatriStem Wound Care Matrix, MatriStem Plastic Surgery Matrix, and MatriStem Hernia Matrix, catering to different medical needs. ACell received its last investment of $8.70M in a Venture Round on 26 April 2011, reflecting investor confidence in the company's innovative medical solutions. With a focus on Health Care and Manufacturing industries, ACell aims to continue providing cutting-edge solutions for tissue and organ repair in both domestic and international surgical settings.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $8.70M | - | 26 Apr 2011 |
No recent news or press coverage available for ACell.
We care about your data, and we'd love to use cookies make your experience better.
